Quantum Genomics
Pharmaceuticals - Paris, Île-de-France, France
Quantum Genomics Employees
Quantum Genomics Details
The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class:BAPAIs for BrainAminopeptidase A Inhibitors.We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure.High blood pressure remains a major public health concern.Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A.The mid-term strategic objective of the company is to sign partnership agreements with major pharmaceutical companies which will take over and bring the products from the BAPAI technology to the market.
Quantum Genomics Technologies
Email Providers
Outlook
Domain Name Services
Cloudflare DNS
Tag Management
Google Tag Manager
Fonts
Google Font API
Hosting
CloudFlare Hosting